XML 68 R58.htm IDEA: XBRL DOCUMENT v3.25.3
Interests in subsidiaries (Tables)
12 Months Ended
Jun. 30, 2025
Investments accounted for using equity method [abstract]  
Summary of interest in subsidiaries
 
The
consolidated
financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policy described in note 2:
 
         
Ownership interest
 
Name
  
Principal place of business /
Country of incorporation
  
2025
%
   
2024
%
 
Kazia Laboratories Pty Ltd
   Australia      100     100
Kazia Research Pty Ltd
   Australia      100     100
Kazia Therapeutics Inc.
   United States of America      100     100
Glioblast Pty Ltd
   Australia      100     100